Psoriasis patient preferences for health-related benefit-risk tradeoffs using choice-format conjoint analysis

被引：0
|
作者：
Armstrong, A. W. [1 ]
Wu, J. [2 ]
Brezinski, E. [2 ]
机构：
[1] Univ Colorado Denver, Aurora, CO USA
[2] Univ Calif Davis, Sacramento, CA 95817 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2014年 / 134卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
312
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 41 条
  • [1] Eliciting Benefit-Risk Preferences and Probability-Weighted Utility Using Choice-Format Conjoint Analysis
    Van Houtven, George
    Johnson, F. Reed
    Kilambi, Vikram
    Hauber, A. Brett
    [J]. MEDICAL DECISION MAKING, 2011, 31 (03) : 469 - 480
  • [2] Using Choice-Format Conjoint Analysis to Assign Meaning to PRO Scores
    Coon, Cheryl D.
    Hauber, A. Brett
    Mohamed, Ateesha F.
    McLeod, Lori D.
    [J]. QUALITY OF LIFE RESEARCH, 2010, 19 : 126 - 127
  • [3] Measuring patient preferences for colorectal cancer screening using a choice-format survey
    Marshall, Deborah A.
    Johnson, F. Reed
    Phillips, Kathryn A.
    Marshall, John K.
    Thabane, Lehana
    Kulin, Nathalie A.
    [J]. VALUE IN HEALTH, 2007, 10 (05) : 415 - 430
  • [4] Hierarchical Bayesian Benefit-Risk Modeling and Assessment Using Choice Based Conjoint
    Mukhopadhyay, Saurabh
    Dilley, Kimberley
    Oladipo, Anthony
    Jokinen, Jeremy
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2019, 11 (01): : 52 - 60
  • [5] PATIENT BENEFIT-RISK PREFERENCES FOR ADVANCED RENAL CELL CARCINOMA TREATMENTS: RESULTS FROM A CONJOINT ANALYSIS STUDY
    Mohamed, A.
    Yang, J. C.
    Hauber, A. B.
    Liu, Z.
    Wong, M.
    Rogerio, J.
    Garay, C.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A236 - A236
  • [6] From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk Tradeoffs
    Tervonen, Tommi
    Pignatti, Francesco
    Postmus, Douwe
    [J]. MEDICAL DECISION MAKING, 2019, 39 (07) : 879 - 885
  • [7] Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit-risk conjoint study.
    Hauber, A. B.
    Mohamed, A. F.
    Johnson, F. R.
    Neary, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Trade-offs between toxicity and progression-free survival in renal cell carcinoma therapies: a choice-format conjoint study of patient preferences
    Wong, M. K.
    Mohamed, A. F.
    Yang, J. C.
    Hauber, A. B.
    Liu, Z.
    Rogerio, J.
    Garay, C. A.
    [J]. BJU INTERNATIONAL, 2012, 109 : 13 - 13
  • [9] Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
    Janine A. van Til
    Maarten J. IJzerman
    [J]. PharmacoEconomics, 2014, 32 : 1 - 4
  • [10] Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
    van Til, Janine A.
    IJzerman, Maarten J.
    [J]. PHARMACOECONOMICS, 2014, 32 (01) : 1 - 4
12345